Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|10|3|234-240

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.10, Iss.3, 2012-09, pp. : 234-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 25-32

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

By Hamada Yoji   Nakamura Jiro  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 245-255

Adis International

Access to resources Recommend Favorite

Statins for Diabetic Cardiovascular Complications

By  

Current Vascular Pharmacology, Vol. 4, Iss. 3, 2006-07 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Oxidative Stress in Development of Cardiovascular Complications in Diabetes Mellitus

By  

Current Vascular Pharmacology, Vol. 4, Iss. 3, 2006-07 ,pp. : 215-227

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat

By Kuzumoto Y.   Kusunoki S.   Kato N.   Kihara M.   Low P.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3085-3093

Springer Publishing Company

Access to resources Recommend Favorite